Industry News

FTC Puts Conditions on Medtronic's Proposed Acquisition of Covidien
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON Gel For The Treatment Of Acne Vulgaris
Merck buys rights to NewLink's Ebola vaccine
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON� Gel For The Treatment Of Acne Vulgaris
Bristol-Myers Squibb to Build New Large-Scale Biologics Manufacturing Facility in Ireland
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
IGI Laboratories, Inc. Announces ANDA Submission
Bracco Diagnostics Inc. Creates First and Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium as Breakthrough Solution for Point-of-Care Use in the CT Suite
BioSyent Pharma Launches New Proktis-M(R) Suppositories
Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed� (Testosterone Undecanoate) Injection
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
Endo Acquires Rights to Natesto� Testosterone Nasal Gel
UPDATE: Insys Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Pediatric Schizophrenia
PetVivo Announces Definitive Merger Agreement with Gel-Del Technologies
Endo Acquires Rights to Natesto� Testosterone Nasal Gel
FDA issues additional guidance for outsourcing facilities that compound sterile human drugs
BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock; Will Add Duchenne Muscular Dystrophy Products to Rare-Disease Portfolio
Beximco Gets Good Manufacturing Practices Approval In Canada
Actamax Updates on Results of Novel Adhesion Barrier Device Trial
CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls; Women to be better informed of risks of valproate use in pregnancy and need for contraception
Actavis to Buy Botox-Maker Allergan for $66 Billion
Soaring generic drug prices draw Senate scrutiny
U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization
GlaxoSmithKline Reports EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade
Shire To Cut Costs With US Site Consolidation, Appoints Interim CFO